However, most subsequent clinical research has focused on androgenetic alopecia specifically, so the strongest evidence base is for pattern hair loss
While that is an opinion, it reflects a growing sentiment that doctors stepping outside the bounds of evidence-based medicine with peptides are leaving themselves exposed to lawsuits
Squalane, Aqua (Water), Coco-Caprylate/Caprate, Glycerin, Sucrose Stearate, Ethyl Macadamiate, Caprylic/Capric Triglyceride, Hydrogenated Starch Hydrolysate, Sucrose Laurate, Polyacrylate Crosspolymer-6, Isoceteth-20, Sodium Polyacrylate, Tocopherol, Hydroxymethoxyphenyl Decanone, Trisodium Ethylenediamine Disuccinate, Malic Acid, Ethylhexylglycerin, Chlorphenesin
This means ARA-290 provides EPO's tissue-protective benefits without the serious risks of polycythemia, increased blood viscosity, and cardiovascular events that limit EPO use